Benincasa Susanna, Azzalini Lorenzo, Carlino Mauro, Bellini Barbara, Giannini Francesco, Zhao Xiaohui, Colombo Antonio
Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy.
Interventional Cardiology, San Raffaele Scientific Institute, Milan, Italy.
Cardiovasc Revasc Med. 2017 Sep;18(6):393-398. doi: 10.1016/j.carrev.2017.03.013. Epub 2017 Mar 14.
The retrograde approach through epicardial collaterals (EC) for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is a challenging procedure. Our study aim was to evaluate the outcomes of patients undergoing CTO PCI using a retrograde approach through epicardial versus non-epicardial collaterals (NEC).
We collected data from our single-center registry of consecutive patients undergoing retrograde CTO PCI, performed by an experienced operator through EC and NEC (septals and bypass grafts). Clinical, angiographic and procedural data were recorded. The primary endpoint (major adverse cardiac events, MACE) was a composite of cardiac death, target-vessel myocardial infarction (MI) and target-vessel revascularization (TVR) on follow-up.
During the study period, 318 CTO PCIs were performed. Of these, 81 procedures (25%) were performed retrogradely in 75 patients (38 using NEC [31 septals, 7 bypass grafts], 37 through EC [34 contralateral, 3 ipsilateral]). Clinical characteristics were balanced between EC and NEC. J-CTO score was 2.1±1.1 and 2.2±1.2, respectively (p=0.92). Collateral tortuosity was more marked in EC. Technical and procedural success was lower in EC (35% vs. 76%, p<0.001; 30% vs. 76%, p<0.001; respectively). There were two perforations (5%) with need for intervention in EC, and none in NEC (p=0.15). After a median follow-up of 443 (331-744) days, MACE were observed in 12.9% (n=4) of EC vs. 5.4% (n=2) in NEC patients (p=0.28).
In our experience, retrograde CTO PCI through EC was associated with lower success rate, and a numerically higher rate of perforation, as compared with NEC. Clinical outcomes on follow-up were similar.
通过心外膜侧支循环(EC)进行慢性完全闭塞病变(CTO)的经皮冠状动脉介入治疗(PCI)是一项具有挑战性的操作。我们的研究目的是评估经心外膜侧支循环与非心外膜侧支循环(NEC)逆行途径进行CTO PCI患者的治疗结果。
我们收集了来自单中心连续接受逆行CTO PCI患者登记处的数据,由经验丰富的术者通过EC和NEC(间隔支和旁路移植血管)进行操作。记录临床、血管造影和手术数据。主要终点(主要不良心脏事件,MACE)是随访时心脏死亡、靶血管心肌梗死(MI)和靶血管血运重建(TVR)的复合终点。
在研究期间,共进行了318例CTO PCI。其中,75例患者(38例使用NEC[31例间隔支,7例旁路移植血管],37例通过EC[34例对侧,3例同侧])进行了81例逆行操作。EC和NEC之间的临床特征均衡。J-CTO评分分别为2.1±1.1和2.2±1.2(p=0.92)。EC中的侧支迂曲更为明显。EC的技术成功率和手术成功率较低(分别为35%对76%,p<0.001;30%对76%,p<0.001)。EC中有2例穿孔(5%)需要干预,NEC中无穿孔(p=0.15)。中位随访443(331-744)天后,EC患者中12.9%(n=4)观察到MACE,NEC患者中为5.4%(n=2)(p=0.28)。
根据我们的经验,与NEC相比,通过EC进行逆行CTO PCI成功率较低,穿孔发生率在数值上更高。随访的临床结果相似。